Showing 1 posts of 1 posts found.
Eisai’s Kisplyx (lenvatinib) has secured recommendation from the Scottish Medicines Consortium, it has been revealed, meaning that patients on the …
NanoSomiX and Beckman Coulter Diagnostics collaborate on blood tests for neurodegenerative diseases
EMA selects TrialAssure anonymisation platform for clinical trial documents
Researchers develop new antifungal compounds with improved safety profile
Lonza and Engitix partner to develop next-generation antibody-drug conjugates
Simris Group appoints Tiffany J Vora as Strategic Advisor